
We radically amplify the impact of astaxanthin in farmed salmon and other species - naturally.
A category tension: how to produce vivid, healthy salmon - naturally and at lower cost
The $20B+ global salmon farming industry relies heavily on synthetic astaxanthin to provide pink pigmentation and to promote fish health. However, pigmentation effectiveness has declined due to feed ingredient conflicts, storage degradation, and the effects of fish stress from multiple sea lice treatments. This creates inefficiencies and higher costs for salmon farmers, who also face increasing consumer demands for natural and sustainable farming solutions.
What we do: Unlock nature’s incredible potential using our patented liposomes
BioUp Aqua has developed a breakthrough liposomal encapsulation technology called BioUp Asta, that dramatically enhances astaxanthin uptake in farmed salmon.
This innovation not only substantially improves pigmentation outcomes at lower doses of synthetic astaxanthin, but also has the potential to make natural astaxanthin more viable and cost-effective. BioUp Asta enables a shift towards natural astaxanthin to better align with trending consumer preferences for naturally sourced ingredients, particularly in premium and organic markets.
Our patented liposome technology results in better astaxanthin bioavailability and improves fish health, product quality, and farm profitability.
BioUp Asta can reduce the cost of pigmentation by more than 50%.
Who we are
BioUp Aqua is a biotechnology venture that utilises patented liposomal technology to deliver lower-cost solutions for pigmenting salmonids.
BioUp Aqua’s experts have deep experience spanning decades in biotechnology, aquaculture, and environmental sustainability.
We focus our R&D programs towards continually improving liposomal solutions for human, animal, and aquaculture health.
FAQs
How does BioUp Aqua’s liposomal encapsulation technology work?
BioUp Aqua uses a patented liposomal encapsulation process to enhance the bioavailability of astaxanthin in salmon feed. By encapsulating astaxanthin in liposomes made from GRAS ingredients, the technology protects the pigment during feed storage and improves digestibility, ensuring more effective astaxanthin uptake into the fish’s muscle tissues and a redder fillet colour.
What are the benefits of BioUp Aqua’s technology for farmers and salmon quality?
BioUp Aqua’s liposomal encapsulation technology reduces astaxanthin levels in feed by more than 50%, significantly cutting costs while delivering consistent, industry-standard pigmentation. This innovation helps farmers meet consumer demands for premium-quality salmon while optimising fish health, growth performance, and productivity.
What trial work has been undertaken to date?
An independently conducted five-month trial at the Huntsman Marine Science Centre in Canada compared liposome-encapsulated astaxanthin with standard formulations during Atlantic salmon feeding trials. Results showed equivalent flesh pigmentation after 90 days at half the astaxanthin dose using liposome formulations, plus improved astaxanthin stability in feed, and good results for salmon health, growth, and feed conversion. These scientific findings validate the liposome-astaxanthin technology’s effectiveness and readiness for scaling.
What are the next steps for the technology to become commercially available?
Pre-commercial trials in seawater environments with industry partners are required to validate the positive trial results in the smaller seawater tanks during the Huntsman trials. This pre-commercial phase will focus on further refining feed formulations and validating technology use at commercial feed production scale (with the partner’s specific feed mix), for synthetic and natural astaxanthin.
A further step will be optimising the production of natural astaxanthin in combination with liposomal technology to ensure commercial scalability and readiness for market.
Can this technology also be used with natural astaxanthin?
BioUp Aqua’s technology has been successfully tested with natural astaxanthin. Access to low cost (RAS grown algae) astaxanthin in conjunction with BioUp Aqua’s proprietary liposomes highlights the ability to provide a cost-effective alternative to synthetic pigment options. Ongoing optimisation in pre-commercial trials will further enhance its application for farmers seeking to align their products with consumer preferences in organic and other sustainable seafood markets.
How does this technology support sustainability in salmon farming?
The liposomal technology reduces the global salmon farming industry’s reliance on synthetic astaxanthin, which lowers petrochemical resource consumption and waste. And the ability to incorporate natural astaxanthin cost-effectively, supports a progressive shift toward more natural and sustainable farming practices.
Team
Core Team
-
Crispin Eley
CHIEF SCIENTIST
BIOUP MIMETIC TECHNOLOGIES, INC
-
Adrian Barker
COMMERCIAL PROGRAMME DIRECTOR
METHANE MITIGATION VENTURES LIMITED
-
Rob Dorey
DIRECTOR & PRINCIPAL
BSP ADVISORY GROUP LIMITED
Advisors
-
Patrick Manning
EXECUTIVE CHAIRMAN
BIOUP MIMETIC TECHNOLOGIES, INC
-
Tom Sturgess
FOUNDER
METHANE MITIGATION VENTURES LIMITED
-
Sam Bowman
MANAGING PARTNER
BLUE ECONOMY CONSULTING GROUP